China approves Sinopharm vaccine for children, teenagers


Women and a child walk by a billboard calling on people to get vaccinated against Covid-19 outside a shopping mall in Beijing, capital of China, on May 24, 2021. - AP

BEIJING (China Daily/ANN): Sinopharm's Covid-19 vaccine has been approved for emergency use for young people ages 3 to 17, after early and midstage clinical trials showed it is safe and can elicit strong immune responses in the age group, the company said in a recent statement.

The approval was granted by the Joint Prevention and Control Mechanism of the State Council, which was set up to deal with the Covid-19 pandemic.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
China , covid-19 , vaccine , Sinopharm , children , teenagers , approval

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read